Zinger Key Points
- Xerox misses Q1 sales and earnings estimates, with equipment and post-sale revenues declining amid macroeconomic uncertainty.
- Xerox reiterates low single-digit revenue growth and free cash flow guidance for FY25, despite Q1 challenges.
- Live on Wednesday June 18: 3 Summer "Power Patterns" Are About to Trigger (One With 90% Win Rate). See Them Here.
Xerox Holdings Corp (NASDAQ: XRX) reported fiscal first-quarter 2025 results on Thursday, including a quarterly sales decline of 3.0% year-on-year to $1.46 billion, missing the analyst consensus of $1.50 billion. Revenues declined 1.1% at constant currency.
Adjusted EPS loss of $(0.06) missed the analyst consensus estimate of $(0.03).
Equipment sales decreased by 2.1%, while post-sale revenue declined by 3.2%.
Also Read: Xerox to Expand Global Print Business with $1.5 Billion Lexmark Buyout
Gross margin declined 30 bps to 29.2%. The equipment margin fell by 310 bps to 27.9%, while the post-sale margin decreased by 50 bps to 29.6%.
The company reported an adjusted operating income of $22 million, compared to $33 million in 2024; the margin declined 70 basis points to 1.5%.
Xerox held $336 million in cash and equivalents as of March 31, 2025. The company used $89 million in operating cash flow for the quarter.
CEO Steve Bandrowczak said that a quarter marked by increasing levels of macroeconomic and trade policy uncertainty, as well as improved sales productivity and the successful integration of IT savvy and other reinvention-enabled operating efficiencies, drove momentum in revenue and a positive adjusted operating income in its seasonally lowest quarter.
FY25 Outlook: The company reiterated a revenue growth of low single-digit growth in constant currency. The company reiterated its free cash flow guidance of $350 million to $400 million.
Xerox maintained an adjusted operating margin outlook of a minimum of 5.0%.
Price Action: XRX stock is up 1.81% at $4.49 premarket at last check on Thursday.
Read Next:
Photo: Shutterstock
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.